Monograph

M05BA07 - Risedronic Acid

Not porphyrinogenic

Rationale

Probably insignificant systemic effects outside bone tissue. Occasional observation of tolerance.

Chemical description

Pyridinyl biphosphonate used in menopausal osteoporosis. Binds to bone tissue where it inhibits osteoclastic activity. Thunell; observed to be tolerated (n=1)

IPNet drug reports

Uneventful use reported in 5 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes M05B / M05BA or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames